Annual D&A
$4.26 M
-$2.77 M-39.41%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual depreciation & amortization is $4.26 million, with the most recent change of -$2.77 million (-39.41%) on December 31, 2023.
- During the last 3 years, TBPH annual D&A has fallen by -$2.72 million (-38.96%).
- TBPH annual D&A is now -50.50% below its all-time high of $8.60 million, reached on December 31, 2021.
Performance
TBPH Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$762.00 K
-$217.00 K-22.17%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly depreciation & amortization is $762.00 thousand, with the most recent change of -$217.00 thousand (-22.17%) on September 30, 2024.
- Over the past year, TBPH quarterly D&A has dropped by -$175.00 thousand (-18.68%).
- TBPH quarterly D&A is now -70.79% below its all-time high of $2.61 million, reached on September 30, 2021.
Performance
TBPH Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$4.34 M
-$175.00 K-3.88%
September 30, 2024
Summary
- As of February 8, 2025, TBPH TTM depreciation & amortization is $4.34 million, with the most recent change of -$175.00 thousand (-3.88%) on September 30, 2024.
- Over the past year, TBPH TTM D&A has dropped by -$527.00 thousand (-10.83%).
- TBPH TTM D&A is now -49.56% below its all-time high of $8.60 million, reached on December 31, 2021.
Performance
TBPH TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TBPH Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.4% | -18.7% | -10.8% |
| 3 y3 years | -39.0% | -70.8% | -43.7% |
| 5 y5 years | +34.4% | +96.4% | -37.8% |
TBPH Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.5% | at low | -62.4% | at low | -49.6% | +1.9% |
| 5 y | 5-year | -50.5% | at low | -70.8% | +96.4% | -49.6% | +1.9% |
| alltime | all time | -50.5% | +60.4% | -70.8% | +96.4% | -49.6% | +516.9% |
Theravance Biopharma Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $762.00 K(-22.2%) | $4.34 M(-3.9%) |
| Jun 2024 | - | $979.00 K(-17.0%) | $4.51 M(+1.2%) |
| Mar 2024 | - | $1.18 M(-16.8%) | $4.46 M(+4.7%) |
| Dec 2023 | $4.26 M(-39.4%) | $1.42 M(+51.2%) | $4.26 M(-12.5%) |
| Sep 2023 | - | $937.00 K(+1.4%) | $4.86 M(-14.6%) |
| Jun 2023 | - | $924.00 K(-5.5%) | $5.69 M(-14.7%) |
| Mar 2023 | - | $978.00 K(-51.7%) | $6.68 M(-4.9%) |
| Dec 2022 | $7.02 M(-18.3%) | $2.02 M(+14.6%) | $7.02 M(+11.9%) |
| Sep 2022 | - | $1.77 M(-7.4%) | $6.28 M(-11.8%) |
| Jun 2022 | - | $1.91 M(+44.3%) | $7.12 M(-6.6%) |
| Mar 2022 | - | $1.32 M(+3.4%) | $7.63 M(-11.3%) |
| Dec 2021 | $8.60 M(+23.3%) | $1.28 M(-50.9%) | $8.60 M(+11.6%) |
| Sep 2021 | - | $2.61 M(+8.0%) | $7.71 M(+8.8%) |
| Jun 2021 | - | $2.42 M(+5.4%) | $7.08 M(+2.3%) |
| Mar 2021 | - | $2.29 M(+491.0%) | $6.92 M(-0.7%) |
| Dec 2020 | $6.97 M(+12.2%) | $388.00 K(-80.4%) | $6.97 M(-9.4%) |
| Sep 2020 | - | $1.98 M(-12.0%) | $7.69 M(+0.9%) |
| Jun 2020 | - | $2.25 M(-3.8%) | $7.63 M(+10.8%) |
| Mar 2020 | - | $2.35 M(+111.6%) | $6.89 M(+10.8%) |
| Dec 2019 | $6.21 M(+96.3%) | $1.11 M(-42.3%) | $6.21 M(+4.2%) |
| Sep 2019 | - | $1.92 M(+26.8%) | $5.96 M(+27.9%) |
| Jun 2019 | - | $1.51 M(-9.5%) | $4.66 M(+18.4%) |
| Mar 2019 | - | $1.67 M(+95.0%) | $3.94 M(+24.4%) |
| Dec 2018 | $3.17 M | $858.00 K(+38.8%) | $3.17 M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $618.00 K(-21.8%) | $3.33 M(-9.1%) |
| Jun 2018 | - | $790.00 K(-12.2%) | $3.66 M(-4.8%) |
| Mar 2018 | - | $900.00 K(-11.6%) | $3.84 M(-4.5%) |
| Dec 2017 | $4.03 M(+29.1%) | $1.02 M(+7.2%) | $4.03 M(-3.8%) |
| Sep 2017 | - | $950.00 K(-2.7%) | $4.18 M(+4.0%) |
| Jun 2017 | - | $976.00 K(-9.9%) | $4.03 M(+14.9%) |
| Mar 2017 | - | $1.08 M(-7.8%) | $3.50 M(+12.3%) |
| Dec 2016 | $3.12 M(+4.3%) | $1.18 M(+48.5%) | $3.12 M(+18.1%) |
| Sep 2016 | - | $791.00 K(+74.2%) | $2.64 M(+2.8%) |
| Jun 2016 | - | $454.00 K(-35.1%) | $2.57 M(-10.2%) |
| Mar 2016 | - | $699.00 K(+0.3%) | $2.86 M(-4.2%) |
| Dec 2015 | $2.99 M(-8.7%) | $697.00 K(-3.2%) | $2.99 M(-2.7%) |
| Sep 2015 | - | $720.00 K(-3.6%) | $3.07 M(-10.4%) |
| Jun 2015 | - | $747.00 K(-9.5%) | $3.43 M(+1.8%) |
| Mar 2015 | - | $825.00 K(+5.6%) | $3.37 M(+2.8%) |
| Dec 2014 | $3.27 M(+23.4%) | $781.00 K(-27.3%) | $3.27 M(+2.7%) |
| Sep 2014 | - | $1.07 M(+56.7%) | $3.19 M(+19.4%) |
| Jun 2014 | - | $686.00 K(-6.3%) | $2.67 M(-0.5%) |
| Mar 2014 | - | $732.00 K(+5.5%) | $2.68 M(+1.1%) |
| Dec 2013 | $2.65 M(-18.4%) | $694.00 K(+24.6%) | $2.65 M(+35.4%) |
| Sep 2013 | - | $557.00 K(-20.3%) | $1.96 M(+39.7%) |
| Jun 2013 | - | $699.00 K(-0.6%) | $1.40 M(+99.4%) |
| Mar 2013 | - | $703.00 K | $703.00 K |
| Dec 2012 | $3.25 M | - | - |
FAQ
- What is Theravance Biopharma annual depreciation & amortization?
- What is the all time high annual D&A for Theravance Biopharma?
- What is Theravance Biopharma annual D&A year-on-year change?
- What is Theravance Biopharma quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Theravance Biopharma?
- What is Theravance Biopharma quarterly D&A year-on-year change?
- What is Theravance Biopharma TTM depreciation & amortization?
- What is the all time high TTM D&A for Theravance Biopharma?
- What is Theravance Biopharma TTM D&A year-on-year change?
What is Theravance Biopharma annual depreciation & amortization?
The current annual D&A of TBPH is $4.26 M
What is the all time high annual D&A for Theravance Biopharma?
Theravance Biopharma all-time high annual depreciation & amortization is $8.60 M
What is Theravance Biopharma annual D&A year-on-year change?
Over the past year, TBPH annual depreciation & amortization has changed by -$2.77 M (-39.41%)
What is Theravance Biopharma quarterly depreciation & amortization?
The current quarterly D&A of TBPH is $762.00 K
What is the all time high quarterly D&A for Theravance Biopharma?
Theravance Biopharma all-time high quarterly depreciation & amortization is $2.61 M
What is Theravance Biopharma quarterly D&A year-on-year change?
Over the past year, TBPH quarterly depreciation & amortization has changed by -$175.00 K (-18.68%)
What is Theravance Biopharma TTM depreciation & amortization?
The current TTM D&A of TBPH is $4.34 M
What is the all time high TTM D&A for Theravance Biopharma?
Theravance Biopharma all-time high TTM depreciation & amortization is $8.60 M
What is Theravance Biopharma TTM D&A year-on-year change?
Over the past year, TBPH TTM depreciation & amortization has changed by -$527.00 K (-10.83%)